Survey Says: "COVID-19 Lockdown Hits Young Faculty and Clinical Trials".

Kent, David G; Knapp, David J H F; Kannan, Nagarajan

Kent, David G; Knapp, David J H F; Kannan, Nagarajan.

Kent DG; York Biomedical Research Institute, Department of Biology, University of York, York, UK. Electronic address: david.kent@york.ac.uk.
Knapp DJHF; Institut de recherche en immunologie et en cancérologie, and Département de pathologie et biologie cellulaire, Université de Montréal, Montreal, QC, Canada. Electronic address: david.knapp@umontreal.ca.
Kannan N; Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Center for Regenerative Medicine, and May Clinic Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: kannan.nagarajan@mayo.edu.

Stem Cell Reports ; 15(1): 1-5, 2020 07 14.

Article in English | MEDLINE | ID: covidwho-610608

ABSTRACT

ABSTRACT

COVID-19 has severely impacted laboratory research. Analysis of the International Society for Stem Cell Research (ISSCR) member survey has highlighted a particular impact on clinical trials and early-career investigators. The stem cell community needs to support young researchers and ensure that stem cell medicine does not lose its momentum.

Subject(s)

Biomedical Research/statistics & numerical data; Clinical Trials as Topic/statistics & numerical data; Pandemics/statistics & numerical data; COVID-19; Coronavirus Infections; Humans; Pneumonia, Viral; Research Personnel; Surveys and Questionnaires

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / Biomedical Research / Pandemics Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Stem Cell Reports Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google